Adverse events associated with budesonide nasal irrigation reported to the US Food and Drug Administration: 2007 to 2022
International Forum of Allergy & Rhinology · 2024
DOI: 10.1002/alr.23232 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Forum of Allergy & Rhinology, 2024. Verfasst von Vinay K Rathi und 6 weiteren Autor:innen. Beteiligte Einrichtung: Division of Rhinology and Sinus Surgery, Department of Otolaryngology - Head and Neck Surgery, Medical University of South Carolina, Charleston, Sout…. Hauptthemen laut MEDLINE: Sinusitis, Rhinitis, Nasal Polyps. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 15 Literaturangaben. Gefördert von: NIDCD NIH HHS, NIH HHS, National Institute on Deafness and Other Communication Disorders.
Themen: Patientensicherheit
Abstract (Originalsprache)
KEYPOINTS Between 2007 and 2022, the FDA received 119 US‐based reports mentioning budesonide nasal irrigation. Most reports were submitted by patients and alerted FDA to off‐label usage of budesonide. Notable adverse events reported to the FDA included headache, dyspnea, and blurred vision.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Rhinology and Sinus Surgery, Department of Otolaryngology - Head and Neck Surgery, Medical University of South Carolina, Charleston, South Carolina, USA.
- Brown University, Providence, Rhode Island, USA.
- Department of Surgery, Ralph H. Johnson VA Medical Center, Charleston, South Carolina, USA.
- Department of Otolaryngology, Harvard Medical, School, Boston, Massachusetts, USA.
- Department of Otolaryngology - Head and Neck Surgery, Massachusetts Eye & Ear Infirmary, Boston, Massachusetts, USA.
Förderung
- NIDCD NIH HHS
- NIH HHS
- National Institute on Deafness and Other Communication Disorders
- National Institutes of Health
Zitieren
APA
Rathi, V. K., Sawicki, N. W., Schlosser, R. J., Soler, Z. M., Scangas, G. A., Workman, A. D., & Gray, S. T. (2024). Adverse events associated with budesonide nasal irrigation reported to the US Food and Drug Administration: 2007 to 2022. International Forum of Allergy & Rhinology. https://doi.org/10.1002/alr.23232
Vancouver
Rathi VK, Sawicki NW, Schlosser RJ, Soler ZM, Scangas GA, Workman AD, et al. Adverse events associated with budesonide nasal irrigation reported to the US Food and Drug Administration: 2007 to 2022. International Forum of Allergy & Rhinology. 2024. doi:10.1002/alr.23232
BibTeX
@article{Rathi2024,
author = {Rathi, Vinay K and Sawicki, Nicholas W and Schlosser, Rodney J and Soler, Zachary M and Scangas, George A and Workman, Alan D and Gray, Stacey T},
title = {Adverse events associated with budesonide nasal irrigation reported to the US Food and Drug Administration: 2007 to 2022},
journal = {International Forum of Allergy & Rhinology},
year = {2024},
doi = {10.1002/alr.23232}
}
EUVIMED